TY  - GEN
AU  - Müller,K A L
AU  - Geisler,T
AU  - Gawaz,M
TI  - Elinogrel, an orally and intravenously available ADP-receptor antagonist. How does elinogrel affect a personalized antiplatelet therapy?
SN  - 2567-5761
PY  - 2013///0115
KW  - Administration, Oral
KW  - Evidence-Based Medicine
KW  - Fibrinolytic Agents
KW  - administration & dosage
KW  - Humans
KW  - Injections, Intravenous
KW  - Platelet Aggregation Inhibitors
KW  - Precision Medicine
KW  - methods
KW  - Purinergic P2Y Receptor Antagonists
KW  - Quinazolinones
KW  - Sulfonamides
KW  - Thrombosis
KW  - drug therapy
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.5482/ha-1192
ER  -